APA (7th ed.) Citation

Descheemaeker, A., Poras, H., Wurm, M., Luccarini, P., Ouimet, T., & Dallel, R. (2022). Dual enkephalinase inhibitor PL37 as a potential novel treatment of migraine: Evidence from a rat model. Brain: A Journal of Neurology, 145(8), 2664. https://doi.org/10.1093/brain/awac139

Chicago Style (17th ed.) Citation

Descheemaeker, Amélie, Hervé Poras, Michel Wurm, Philippe Luccarini, Tanja Ouimet, and Radhouane Dallel. "Dual Enkephalinase Inhibitor PL37 as a Potential Novel Treatment of Migraine: Evidence from a Rat Model." Brain: A Journal of Neurology 145, no. 8 (2022): 2664. https://doi.org/10.1093/brain/awac139.

MLA (9th ed.) Citation

Descheemaeker, Amélie, et al. "Dual Enkephalinase Inhibitor PL37 as a Potential Novel Treatment of Migraine: Evidence from a Rat Model." Brain: A Journal of Neurology, vol. 145, no. 8, 2022, p. 2664, https://doi.org/10.1093/brain/awac139.